Radiation-induced low-grade fibromyxoid sarcoma of the chest wall nine years subsequent to radiotherapy for breast carcinoma: A case report

Shibata,Shino; Shiraishi,Kenshiro; Yamashita,Hideomi; Kobayashi,Reiko; Nakagawa,Keiichi

doi:10.3892/ol.2016.4221

Radiation-induced low-grade fibromyxoid sarcoma of the chest wall nine years subsequent to radiotherapy for breast carcinoma: A case report

Authors:
- Shino Shibata
- Kenshiro Shiraishi
- Hideomi Yamashita
- Reiko Kobayashi
- Keiichi Nakagawa
View Affiliations

Affiliations: Department of Radiation Oncology, Kawasaki Saiwai Hospital, Kawasaki, Kanagawa 212‑0014, Japan, Department of Radiology, University of Tokyo Hospital, Tokyo 113‑0033, Japan
Published online on: February 10, 2016 https://doi.org/10.3892/ol.2016.4221
Pages: 2520-2524

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study reports a case of low-grade fibromyxoid sarcoma that occurred in a 62-year-old woman 9 years subsequent to whole breast irradiation for a carcinoma of the left breast, and 18 years following chemotherapy and radiotherapy (RT) for non‑Hodgkin's lymphoma (NHL; diagnosed at the age of 43). The patient was 53 years of age when a cT2N0M0 stage IIA breast tumor was identified and excised. A 2.5 cm diameter nodule with dimpling in the upper‑outer region of the left breast was detected. Pathological examination revealed that the tumor was an invasive ductal carcinoma, of a solid tubular type. The patient was treated with post‑surgical whole breast RT. The left breast received 46 Gy in 23 fractions (2 Gy per fraction) for 4 weeks and 3 days, followed by a cone down boost of 14 Gy in 7 fractions (2 Gy per fraction); therefore a total dose of 60 Gy in 30 fractions was administered. In total, 9 years subsequent to RT, the patient observed a small lump in the left chest wall. The patient underwent excision of the tumor and pectoralis major fascia. Microscopically, the tumor consisted of atypical spindle cells with myxoid stroma. Pathologists concluded that the tumor was a low‑grade fibromyxoid sarcoma. Since the tumor developed from tissue in a previously irradiated region, it was considered to be RT‑induced, and was classified using the radiation‑induced sarcoma (RIS) criteria as dictated by Cahan. Although the majority of RIS cases are angiosarcomas, a rare, low‑grade fibromyxoid sarcoma was observed in the present study. The present study hypothesizes that there may have been an overlap region between the RT for supraclavicular nodes of NHL and the whole breast RT for primary breast cancer, due to the results of a retrospective dose reconstruction undertaken by the present study. The patient remained clinically stable for 4 years thereafter, until 2008 when the patient experienced a local relapse and underwent surgery. On 19 October 2011, the patient succumbed to RIS. The current study suggests that the RT history of a patient requires consideration due to the possible development of RIS, including the development of a low‑grade fibromyxoid sarcoma, which may lead to a poor prognosis.

View Figures

View References

1	Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, et al: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 378:1707–1716. 2011. View Article : Google Scholar : PubMed/NCBI
2	Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, et al: Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol. 9:543–549. 2002. View Article : Google Scholar : PubMed/NCBI
3	Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH and Harris JR: Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 52:406–414. 2002. View Article : Google Scholar : PubMed/NCBI
4	Toyoshima M, Okamura C, Niikura H, Ito K and Yaegashi N: Epithelioid leiomyosarcoma of the uterine cervix: a case report and review of the literature. Gynecol Oncol. 97:957–960. 2005. View Article : Google Scholar : PubMed/NCBI
5	Beck A: The question of whether radiation-induced sarcoma contributes to the pathogenesis of sarcoma. Munch Med Wochenschr. 69:623–625. 1922.(In German).
6	Warren S and Sommer GN: Fibrosarcoma of the soft parts with special reference to recurrence and metastasis. Arch Surg. 33:425–450. 1936. View Article : Google Scholar
7	Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW and Coley BL: Sarcoma arising in irradiated bone: Report of eleven cases 1948. Cancer. 82:8–34. 1998. View Article : Google Scholar : PubMed/NCBI
8	de Berrington Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M and Ron E: Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer. 102:220–226. 2010. View Article : Google Scholar : PubMed/NCBI
9	Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS and Evans HL: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 1225 patients. Cancer. 97:2530–2543. 2003. View Article : Google Scholar : PubMed/NCBI
10	Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, Brennan MF and Singer S: Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 28:2064–2069. 2010. View Article : Google Scholar : PubMed/NCBI
11	Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Smeland S and Fosså SD: Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival? Br J Cancer. 106:297–306. 2012. View Article : Google Scholar : PubMed/NCBI
12	Cox JD, Stetz J and Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
13	Young RJ, Brown NJ, Reed MW, Hughes D and Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010. View Article : Google Scholar : PubMed/NCBI
14	Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, et al: Angiosarcoma: Clinical and molecular insights. Ann Surg. 251:1098–1106. 2010. View Article : Google Scholar : PubMed/NCBI
15	Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK and Hamre M: Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys. 52:1231–1237. 2002. View Article : Google Scholar : PubMed/NCBI
16	Adem C, Reynolds C, Ingle JN and Nascimento AG: Primary breast sarcoma: Clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer. 91:237–241. 2004.PubMed/NCBI
17	Evans HL: Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 88:615–619. 1987.PubMed/NCBI
18	Evans HL: Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. 17:595–600. 1993. View Article : Google Scholar : PubMed/NCBI
19	Karlsson P, Holmberg E, Samuelsson A, Johansson KA and Wallgren A: Soft tissue sarcoma after treatment for breast cancer - a Swedish population-based study. Eur J Cancer. 34:2068–2075. 1998. View Article : Google Scholar : PubMed/NCBI
20	Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J and de Vathaire F: Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat. 89:277–288. 2005. View Article : Google Scholar : PubMed/NCBI
21	Wijnmaalen A, van Ooijen B, van Geel BN, Henzen-Logmans SC and Treurniet-Donker AD: Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: Three case reports and a review of the literature. Int J Radiat Oncol Biol Phys. 26:135–139. 1993. View Article : Google Scholar : PubMed/NCBI
22	Monroe AT, Feigenberg SJ and Mendenhall NP: Angiosarcoma after breast-conserving therapy. Cancer. 97:1832–1840. 2003. View Article : Google Scholar : PubMed/NCBI
23	Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X and Fourquet A: Radiation-induced sarcomas after radiotherapy for breast carcinoma: A large-scale single-institution review. Cancer. 104:856–863. 2005. View Article : Google Scholar : PubMed/NCBI
24	Philibert D and Cattran D: Remission of proteinuria in primary glomerulonephritis: We know the goal but do we know the price? Nat Clin Pract Nephrol. 4:550–559. 2008. View Article : Google Scholar : PubMed/NCBI